Pathophysiologic implications of reduced podocyte number in a rat model of progressive glomerular injury

被引:160
作者
Macconi, D
Bonomelli, M
Benigni, A
Plati, T
Sangalli, F
Longaretti, L
Conti, S
Kawachi, H
Hill, P
Remuzzi, G
Remuzzi, A
机构
[1] Mario Negri Inst Pharmacol Res, I-24125 Bergamo, Italy
[2] Niigata Univ, Grad Sch Med & Dent Sci, Inst Nephrol, Dept Cell Biol, Niigata 95021, Japan
[3] Osped Riuniti Bergamo, Azienda Osped, Unit Nephrol & Dialysis, I-24100 Bergamo, Italy
关键词
D O I
10.2353/ajpath.2006.050398
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Changes in podocyte number or density have been suggested to play an important role in renal disease progression. Here, we investigated the temporal relationship between glomerular podocyte number and development of proteinuria and glomerulosclerosis in the male Munich Wistar Fromter (MWF) rat. We also assessed whether changes in podocyte number affect podocyte function and focused specifically on the slit diaphragm-associated protein nephrin. Age-matched Wistar rats were used as controls. Estimation of podocyte number per glomerulus was determined by digital morphometry of WT1-positive cells. MWF rats developed moderate hypertension, massive proteinuria, and glomerulosclerosis with age. Glomerular hypertrophy was already observed at 10 weeks of age and progressively increased thereafter. By contrast, mean podocyte number per glomerulus was lower than normal in young animals and further decreased with time. As a consequence, the capillary tuft volume per podocyte was more than threefold increased in older rats. Electron microscopy showed important changes in podocyte structure of MWF rats, with expansion of podocyte bodies surrounding glomerular filtration membrane. Glomerular nephrin expression was markedly altered in MWF rats and inversely correlated with both podocyte loss and proteinuria. Our findings suggest that reduction in podocyte number is an important determinant of podocyte dysfunction and progressive impairment of the glomerular permselectivity that lead to the development of massive proteinuria and ultimately to renal scarring.
引用
收藏
页码:42 / 54
页数:13
相关论文
共 46 条
[21]  
Macconi D, 2000, J AM SOC NEPHROL, V11, P477, DOI 10.1681/ASN.V113477
[22]   Podocyte number predicts long-term urinary albumin excretion in Pima Indians with Type II diabetes and microalbuminuria [J].
Meyer, TW ;
Bennett, PH ;
Nelson, RG .
DIABETOLOGIA, 1999, 42 (11) :1341-1344
[23]   Verotoxin-1-induced up-regulation of adhesive molecules renders microvascular endothelial cells thrombogenic at high shear stress [J].
Morigi, M ;
Galbusera, M ;
Binda, E ;
Imberti, B ;
Gastoldi, S ;
Remuzzi, A ;
Zoja, C ;
Remuzzi, G .
BLOOD, 2001, 98 (06) :1828-1835
[24]  
MUNDLOS S, 1993, DEVELOPMENT, V119, P1329
[25]   Urinary excretion of podocytes in patients with diabetic nephropathy [J].
Nakamura, T ;
Ushiyama, C ;
Suzuki, S ;
Hara, M ;
Shimada, N ;
Ebihara, I ;
Koide, H .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 (09) :1379-1383
[26]   MORPHOMETRY OF THE RENAL CORPUSCLE DURING POSTNATAL-GROWTH AND COMPENSATORY HYPERTROPHY [J].
OLIVETTI, G ;
ANVERSA, P ;
MELISSARI, M ;
LOUD, AV .
KIDNEY INTERNATIONAL, 1980, 17 (04) :438-454
[27]   Podocyte loss and progressive glomerular injury in type II diabetes [J].
Pagtalunan, ME ;
Miller, PL ;
JumpingEagle, S ;
Nelson, RG ;
Myers, BD ;
Rennke, HG ;
Coplon, NS ;
Sun, LM ;
Meyer, TW .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (02) :342-348
[28]   Cell biology of the glomerular podocyte [J].
Pavenstädt, H ;
Kriz, W ;
Kretzler, M .
PHYSIOLOGICAL REVIEWS, 2003, 83 (01) :253-307
[29]   Viable podocytes detach in experimental diabetic nephropathy: Potential mechanism underlying glomerulosclerosis [J].
Petermann, AT ;
Pippin, J ;
Krofft, R ;
Blonski, M ;
Griffin, S ;
Durvasula, R ;
Shankland, SJ .
NEPHRON EXPERIMENTAL NEPHROLOGY, 2004, 98 (04) :E114-E123
[30]   DNA damage is a novel response to sublytic complement CSb-9-induced injury in podocytes [J].
Pippin, JW ;
Durvasula, R ;
Petermann, A ;
Hiromura, K ;
Couser, WG ;
Shankland, SJ .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (06) :877-885